Buzzy, buzzy bee-gles
The phrase ‘panel review’ is buzzing around the legal market like a swarm of buzzy bees bumping up against the mother of all honey pots. This week they have been flapping around the medical sector, first with German pharmaceutical giant Bayer announcing the who’s who on its new US and Emea panel, then with the […]